Literature DB >> 25815297

Real-time liquid biopsies become a reality in cancer treatment.

Niki Karachaliou1, Clara Mayo-de-Las-Casas1, Miguel Angel Molina-Vila1, Rafael Rosell1.   

Abstract

Entities:  

Year:  2015        PMID: 25815297      PMCID: PMC4356857          DOI: 10.3978/j.issn.2305-5839.2015.01.16

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  14 in total

Review 1.  Platelets effects on tumor growth.

Authors:  Hadi A Goubran; Julie Stakiw; Mirjana Radosevic; Thierry Burnouf
Journal:  Semin Oncol       Date:  2014-04-23       Impact factor: 4.929

2.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

3.  Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer.

Authors:  Sandra Misale; Sabrina Arena; Simona Lamba; Giulia Siravegna; Alice Lallo; Sebastijan Hobor; Mariangela Russo; Michela Buscarino; Luca Lazzari; Andrea Sartore-Bianchi; Katia Bencardino; Alessio Amatu; Calogero Lauricella; Emanuele Valtorta; Salvatore Siena; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

Review 4.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

5.  Platelets actively sequester angiogenesis regulators.

Authors:  Giannoula Lakka Klement; Tai-Tung Yip; Flavia Cassiola; Lena Kikuchi; David Cervi; Vladimir Podust; Joseph E Italiano; Erin Wheatley; Abdo Abou-Slaybi; Elise Bender; Nava Almog; Mark W Kieran; Judah Folkman
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

6.  Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.

Authors:  Dagmar Schumacher; Boris Strilic; Kishor Kumar Sivaraj; Nina Wettschureck; Stefan Offermanns
Journal:  Cancer Cell       Date:  2013-06-27       Impact factor: 31.743

7.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

8.  "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.

Authors:  Marius Ilie; Véronique Hofman; Elodie Long-Mira; Eric Selva; Jean-Michel Vignaud; Bernard Padovani; Jérôme Mouroux; Charles-Hugo Marquette; Paul Hofman
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

10.  Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.

Authors:  J Nilsson; J Skog; A Nordstrand; V Baranov; L Mincheva-Nilsson; X O Breakefield; A Widmark
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more
  54 in total

1.  An Automated Microfluidic Assay for Photonic Crystal Enhanced Detection and Analysis of an Antiviral Antibody Cancer Biomarker in Serum.

Authors:  Caitlin M Race; Lydia E Kwon; Myles T Foreman; Qinglan Huang; Hakan Inan; Sailaja Kesiraju; Phuong Le; Sung Jun Lim; Andrew M Smith; Richard C Zangar; Utkan Demirci; Karen S Anderson; Brian T Cunningham
Journal:  IEEE Sens J       Date:  2017-11-24       Impact factor: 3.301

Review 2.  The biological significance and clinical applications of exosomes in ovarian cancer.

Authors:  Kalpana Deepa Priya Dorayappan; John J Wallbillich; David E Cohn; Karuppaiyah Selvendiran
Journal:  Gynecol Oncol       Date:  2016-04-10       Impact factor: 5.482

3.  Clinical perception and simple laboratory tests: do not mistake the finger pointing at the moon.

Authors:  Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-08

4.  Microarray-based SNP genotyping to identify genetic risk factors of triple-negative breast cancer (TNBC) in South Indian population.

Authors:  M Aravind Kumar; Vineeta Singh; Shaik Mohammad Naushad; Uday Shanker; M Lakshmi Narasu
Journal:  Mol Cell Biochem       Date:  2017-09-16       Impact factor: 3.396

Review 5.  cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?

Authors:  Tomasz Kolenda; Kacper Guglas; Dawid Baranowski; Joanna Sobocińska; Magda Kopczyńska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-11

Review 6.  cfDNA analysis from blood in melanoma.

Authors:  Miguel A Molina-Vila; Clara Mayo de-Las-Casas; Jordi Bertran-Alamillo; Nuria Jordana-Ariza; María González-Cao; Rafael Rosell
Journal:  Ann Transl Med       Date:  2015-11

7.  Technological advances in precision medicine and drug development.

Authors:  Elaine Maggi; Nicole E Patterson; Cristina Montagna
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-05-05

Review 8.  Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer.

Authors:  Fariz Nurwidya; Jamal Zaini; Andika Chandra Putra; Sita Andarini; Achmad Hudoyo; Elisna Syahruddin; Faisal Yunus
Journal:  Chonnam Med J       Date:  2016-09-23

9.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

10.  Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer.

Authors:  Xiaochang Qiu; Haoran Zhang; Yongheng Zhao; Jing Zhao; Yunyan Wan; Dezhi Li; Zhouhong Yao; Dianjie Lin
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-24       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.